Retatrutide Research Peptide

For Research Use Only. Not for human or veterinary use.

What it is

Retatrutide is a synthetic triple-receptor agonist peptide, supplied as a lyophilized powder for laboratory reconstitution. Retatrutide is currently in Phase 3 investigational clinical trials and is not FDA-approved for any use.

Referenced in research

Published trial data describes triple-receptor agonist research in metabolic contexts; this listing is provided for research reference only.

Compliance note (internal): Highest compliance risk in the catalog. FDA issued a warning letter (March 2026) to another seller specifically over retatrutide sales. Hold for legal review — do not activate this listing until counsel has signed off.

Purity & Testing

Each lot is independently verified by a third-party laboratory via HPLC/MS prior to listing. Certificate of Analysis available on request.

Not a drug, food, or cosmetic. Sold only to qualified researchers who agree to our Terms of Sale.